Mouse models of glioma
- PMID: 25698543
- DOI: 10.1016/j.jocn.2014.10.013
Mouse models of glioma
Abstract
Gliomas are the most common primary tumour in the central nervous system in adults. The pathological hallmark of gliomas is their propensity for extensive infiltration into the surrounding brain parenchyma which results in tumour recurrence. Despite the use of optimal surgical removal and adjuvant therapies the most aggressive of these tumours, glioblastoma multiforme, has a poor patient prognosis, with median survival of less than 15 months. In this review, we discuss mouse glioma models that have been utilised to advance our basic knowledge of the processes involved in gliomagenesis and their use in the testing of novel therapies and treatment regimens in the preclinical setting.
Keywords: Brain tumour; Glioma; Mouse model; Therapy.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Central nervous system gliomas.Crit Rev Oncol Hematol. 2017 May;113:213-234. doi: 10.1016/j.critrevonc.2017.03.021. Epub 2017 Mar 22. Crit Rev Oncol Hematol. 2017. PMID: 28427510 Review.
-
Glioma models.Biochim Biophys Acta. 2001 Aug 31;1551(1):M19-27. doi: 10.1016/s0304-419x(01)00027-0. Biochim Biophys Acta. 2001. PMID: 11553418 Review.
-
Applications of mouse glioma models in preclinical trials.Mutat Res. 2005 Aug 25;576(1-2):54-65. doi: 10.1016/j.mrfmmm.2004.08.023. Mutat Res. 2005. PMID: 16011838 Review.
-
Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.J Pathol. 2016 Jul;239(3):355-64. doi: 10.1002/path.4734. Epub 2016 Jun 10. J Pathol. 2016. PMID: 27125842 Free PMC article.
-
Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.Cancer Lett. 2013 May 1;331(2):139-46. doi: 10.1016/j.canlet.2012.12.024. Epub 2013 Jan 20. Cancer Lett. 2013. PMID: 23340179 Review.
Cited by
-
PTEN-Long inhibits the biological behaviors of glioma cells.Am J Transl Res. 2024 Jul 15;16(7):2840-2851. doi: 10.62347/QHCA5842. eCollection 2024. Am J Transl Res. 2024. PMID: 39114725 Free PMC article.
-
Nanocarrier-based drug combination therapy for glioblastoma.Theranostics. 2020 Jan 1;10(3):1355-1372. doi: 10.7150/thno.38147. eCollection 2020. Theranostics. 2020. PMID: 31938069 Free PMC article. Review.
-
Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics.Regen Biomater. 2021 Nov 12;8(6):rbab062. doi: 10.1093/rb/rbab062. eCollection 2021 Dec. Regen Biomater. 2021. PMID: 34868634 Free PMC article. Review.
-
Focus on current and emerging treatment options for glioma: A comprehensive review.World J Clin Oncol. 2024 Apr 24;15(4):482-495. doi: 10.5306/wjco.v15.i4.482. World J Clin Oncol. 2024. PMID: 38689623 Free PMC article. Review.
-
KRAS gene polymorphisms are associated with the risk of glioma: a two-center case-control study.Transl Pediatr. 2021 Mar;10(3):579-586. doi: 10.21037/tp-20-359. Transl Pediatr. 2021. PMID: 33850816 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical